Larry Mathis Financial Planning LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 6,155 shares of the exchange traded fund’s stock, valued at approximately $786,000.
A number of other hedge funds also recently made changes to their positions in the company. Wealth Management Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at $547,000. Banque Pictet & Cie SA raised its stake in SPDR S&P Biotech ETF by 24.1% during the fourth quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after purchasing an additional 12,595 shares in the last quarter. Apella Capital LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at $490,000. Keystone Investors PTE Ltd. bought a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $12,022,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its stake in shares of SPDR S&P Biotech ETF by 106.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after buying an additional 13,729 shares in the last quarter.
SPDR S&P Biotech ETF Trading Up 2.5%
Shares of NYSEARCA XBI opened at $155.38 on Friday. The firm’s 50-day moving average price is $135.24 and its 200-day moving average price is $128.70. The stock has a market capitalization of $9.91 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12-month low of $82.04 and a 12-month high of $155.93.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
